BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/20/2024 3:53:46 AM | Browse: 36 | Download: 75
 |
Received |
|
2024-08-21 06:10 |
|
Peer-Review Started |
|
2024-07-31 10:56 |
|
First Decision by Editorial Office Director |
|
2024-10-25 04:17 |
|
Return for Revision |
|
2024-10-25 04:17 |
|
Revised |
|
2024-10-30 09:49 |
|
Publication Fee Transferred |
|
2024-11-15 14:37 |
|
Second Decision by Editor |
|
2024-11-15 02:37 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-11-15 06:15 |
|
Articles in Press |
|
2024-11-15 06:15 |
|
Edit the Manuscript by Language Editor |
|
2024-11-25 14:36 |
|
Typeset the Manuscript |
|
2024-12-12 06:49 |
|
Publish the Manuscript Online |
|
2024-12-20 03:53 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Infectious Diseases |
| Manuscript Type |
Clinical Trials Study |
| Article Title |
CXCR5+CD8+ T cells as immune regulators in HBeAg-positive chronic hepatitis B under interferon-alpha treatment
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zhen-Yu Xu, Zhong-Shang Dai, Guo-Zhong Gong and Min Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Changsha Science and Technology Program |
kq2022397 |
| Natural Science Foundation of Hunan Province (Departmental Joint Fund) |
2023JJ60440 |
| Research Program of Health Commission of Hunan Province |
202303088786 |
| Clinical Medical Research Center for Viral Hepatitis of Hunan Province |
2023SK4009 |
| The Scientific Research Program of FuRong Laboratory |
2023SK2108 |
|
| Corresponding Author |
Min Zhang, MD, Institute of Hepatology and Department of Infectious Diseases, The Second Xiangya Hospital, Central South University, No. 139 Renmin Road Central, Changsha 410011, Hunan Province, China. zhangmin001@csu.edu.cn |
| Key Words |
CXCR5; PD-L1; IL-21; Pegylated interferon-alpha; Chronic hepatitis B |
| Core Tip |
This study highlights the pivotal role of CXCR5+CD8+ T cells in chronic hepatitis B (CHB) during pegylated interferon-alpha treatment. Our findings reveal that patients who achieved sustained serologic response exhibited higher baseline and treatment levels of CXCR5+CD8+ T cells, suggesting a connection between CXCR5 expression and IFN-induced antiviral immune responses. This research emphasizes the importance of CXCR5+CD8+ T cells as a potential biomarker for monitoring treatment efficacy in CHB patients. |
| Publish Date |
2024-12-20 03:53 |
| Citation |
Xu ZY, Dai ZS, Gong GZ, Zhang M. CXCR5+CD8+ T cells as immune regulators in HBeAg-positive chronic hepatitis B under interferon-alpha treatment. World J Gastroenterol 2025; 31(3): 99833 |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i3/99833.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i3.99833 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
